Pre-Term Birth in the US: A Growing Epidemic
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
According to a recent Institute of Medicine report preterm birth has increased by 30% over the past 25 years in the United States. Birth before 37 completed weeks now comprises 12.5% of all US births and poses a major public health problem and expense. Why is the rate of prematurity increasing even as the standard of living goes up? Our guest today is Dr. Jay Iams who is a nationally recognized expert on pre-term labor. He is the Frederick Zuspan Professor of Obstetrics and Gynecology and Vice Chair of the Department at Ohio State University College of Medicine and Public Health. With hundreds of publications in the medical literature he is a member of steering committed for the Maternal Fetal Medicine Network of National Institute of Child Health and Human Development.
Overview
According to a recent Institute of Medicine report preterm birth has increased by 30% over the past 25 years in the United States. Birth before 37 completed weeks now comprises 12.5% of all US births and poses a major public health problem and expense. Why is the rate of prematurity increasing even as the standard of living goes up? Our guest today is Dr. Jay Iams who is a nationally recognized expert on pre-term labor. He is the Frederick Zuspan Professor of Obstetrics and Gynecology and Vice Chair of the Department at Ohio State University College of Medicine and Public Health. With hundreds of publications in the medical literature he is a member of steering committed for the Maternal Fetal Medicine Network of National Institute of Child Health and Human Development.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?